Document Detail

Treatment of neuroblastoma with human natural antibodies.
MedLine Citation:
PMID:  18558369     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: The response data in patients with relapsed high-risk neuroblastoma justify the further evaluation of this immunotherapeutic approach. For this purpose a standardized pharmaceutical product generated by screening and pooling the plasma of selected blood donors would be of benefit.
Rudolf Erttmann
Related Documents :
7788169 - Antibodies to klebsiella pneumoniae, escherichia coli and proteus mirabilis in the sera...
3341559 - Circulating immune complex, endotoxin, and biliary infection in patients with biliary o...
2757929 - An investigation into the incidence of auto-immune disorders in patients with localized...
3049839 - Serodiagnosis of early lyme disease: analysis of igm and igg antibody responses by usin...
6781799 - Iga glomerulonephritis (berger's disease): evidence of high serum levels of polymeric iga.
15817659 - Salivary gland and peripheral blood t helper 1 and 2 cell activity in sjögren's syndro...
20150229 - Wake-up test decrease shunts insertion during carotid endarterectomy under general anes...
8846749 - The early effects of intravenous l-propionyl carnitine on ulcerative trophic lesions of...
11350449 - Percutaneous endoscopic gastrostomy in patients with ventriculoperitoneal shunts.
Publication Detail:
Type:  Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article     Date:  2008-04-15
Journal Detail:
Title:  Autoimmunity reviews     Volume:  7     ISSN:  1568-9972     ISO Abbreviation:  Autoimmun Rev     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-06-18     Completed Date:  2008-08-26     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  101128967     Medline TA:  Autoimmun Rev     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  496-500     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Neoplasm / blood,  therapeutic use*
Child, Preschool
Cytotoxicity, Immunologic
Immunoglobulin M / immunology,  therapeutic use
Neuroblastoma / drug therapy*,  immunology,  pathology
Reg. No./Substance:
0/Antibodies, Neoplasm; 0/Immunoglobulin M

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
Next Document:  Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.